Who Are We

Today, Humphries has evolved into a renowned consulting company in the pharmaceutical industry on the East Coast of the United States. We are a pioneering team engaged in international pharmaceutical development, registration, and business consulting, spanning across both China and the United States. The company focuses on FDA and NMPA registration and consulting services, providing a series of services for domestic and international clients, including project evaluation, preparation of submission documents, document polishing, eCTD submissions, communication with regulatory agencies, and project management for clinical trials conducted in countries such as the United States, India, Canada, and China. We also assist pharmaceutical and investment enterprises in the United States and China with project evaluations, new drug valuations, calculation of transaction terms, and project/company mergers. Humphries is committed to seizing opportunities, facing challenges, and realizing the modernization dream of the pharmaceutical industry alongside all pharmaceutical professionals in China.